MedPath

Tea Tree Lip Balm, SPF 15

Drug Facts

Approved
Approval ID

ce11b043-0290-4c18-afbc-df4e49656c31

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Apr 28, 2025

Manufacturers
FDA

OraLabs

DUNS: 801824756

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Octinoxate, Oxybenzone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63645-176
Application Number352
Product Classification
M
Marketing Category
C200263
G
Generic Name
Octinoxate, Oxybenzone
Product Specifications
Route of AdministrationTOPICAL
Effective DateApril 28, 2025
FDA Product Classification

INGREDIENTS (5)

SUNFLOWER OILInactive
Quantity: 304 mg in 1 g
Code: 3W1JG795YI
Classification: IACT
WHITE WAXInactive
Quantity: 305 mg in 1 g
Code: 7G1J5DA97F
Classification: IACT
ACETYLATED LANOLINInactive
Quantity: 97 mg in 1 g
Code: 2X654GD19H
Classification: IACT
OCTINOXATEActive
Quantity: 20 mg in 1 g
Code: 4Y5P7MUD51
Classification: ACTIB
OXYBENZONEActive
Quantity: 45 mg in 1 g
Code: 95OOS7VE0Y
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tea Tree Lip Balm, SPF 15 - FDA Drug Approval Details